2nd Quarter - Report

THE ADVOCACY GROUP for EMERGENT BIOSOLUTIONS

Period 2nd Quarter 2018 Filed Jul 20, 2018 Signed by GEORGE A. RAMONAS

Official filing
Firm
THE ADVOCACY GROUP
Client
EMERGENT BIOSOLUTIONS
Income
$30,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Disaster Planning/Emergencies DIS

FY 2019 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government Re-authorization of the Pandemic and All-Hazards Preparedness Act NDAA - provisions related to biological and chemical defense

LobbyistCovered position, as disclosed
ROBERT J DOTCHIN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Homeland Security, Dept of (DHS)

Budget/Appropriations BUD

FY 2019 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government Re-authorization of the Pandemic and All-Hazards Preparedness Act NDAA - provisions related to biological and chemical defense

LobbyistCovered position, as disclosed
ROBERT J DOTCHIN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Homeland Security, Dept of (DHS)

Homeland Security HOM

FY 2019 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government Re-authorization of the Pandemic and All-Hazards Preparedness Act NDAA - provisions related to biological and chemical defense

LobbyistCovered position, as disclosed
ROBERT J DOTCHIN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Homeland Security, Dept of (DHS)

Defense DEF

NDAA - provisions related to biological and chemical defense

LobbyistCovered position, as disclosed
ROBERT J DOTCHIN —

Contacted: HOUSE OF REPRESENTATIVES; Homeland Security, Dept of (DHS); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.